状细胞疾病和血栓形成之间的相互作用:单一中心对病理生理学和潜在危险因素的经验
Rafail Tzanninis1, Efthymia Vlachaki2, Eleftheria Lefkou3
1Faculty of Medicine, University of Thessaly, 41334 Larisa, Greece.
Hematology reports
|September 22, 2025
概括
状细胞病 (SCD) 患者表现出高凝血状态,增加了血栓形成的风险. 抗凝剂治疗和剂量是预防复发性静脉血栓栓塞 (VTE) 事件的重要因素.
科学领域:
- 血液学 血液学 血液学
- 血管医学 血管医学
- 遗传学 是一个遗传学.
背景情况:
- 状细胞疾病 (SCD) 是一种普遍存在的遗传性疾病,其特征是高凝血状态.
- SCD与显著的凝血异常有关,增加了血栓事件的风险.
研究的目的:
- 为了研究状细胞病患者血栓形成的危险因素.
- 检查抗凝剂和抗血小板治疗在SCD患者静脉血栓塞栓症 (VTE) 管理中的作用.
主要方法:
- 1999-2024年46名SCD患者的单中心回顾性观察性研究.
- 对人口统计数据,Hb基因型,病史,抗血栓治疗和静脉瘤复发的分析.
- 多变量分析以确定血栓形成的统计学上显著的风险因素.
主要成果:
- 12名患者 (26.1%) 发生了血栓形成,主要是HbS/β-thal基因型.
- 在研究队列中,VTE的患病率为17.4%.
- 抗凝剂治疗,其剂量,年龄和抗血小板治疗与血栓形成风险有显著的相关性.
结论:
- 研究结果证实SCD和血栓事件之间存在强烈的关联.
- 尽管有可用的治疗方法,但SCD患者的血栓形成的管理仍然具有挑战性.
- 抗凝剂治疗和剂量是管理SCD中VTE风险的关键因素.
更多相关视频
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.9K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
20.3K
相关概念视频
Venous Thrombosis I: Introduction
375
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
375
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Multiple Allele Traits
38.0K
The Concept of Multiple Allelism
38.0K
Peripheral Artery Disease I: Introduction
314
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
314
Extrinsic and Intrinsic Pathways of Hemostasis
12.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.1K
